[English] 日本語
Yorodumi
- PDB-8k4v: Crystal structure of HLA-A*11:01 in complex with KRAS G12R peptid... -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 8k4v
TitleCrystal structure of HLA-A*11:01 in complex with KRAS G12R peptide (VVVGARGVGK)
Components
  • Beta-2-microglobulin
  • HLA class I histocompatibility antigen, A alpha chain
  • KRAS G12R peptide (VVVGARGVGK)
KeywordsIMMUNE SYSTEM / cancer immunotherapy
Function / homology
Function and homology information


forebrain astrocyte development / positive regulation of memory T cell activation / T cell mediated cytotoxicity directed against tumor cell target / TAP complex binding / Golgi medial cisterna / positive regulation of CD8-positive, alpha-beta T cell activation / CD8-positive, alpha-beta T cell activation / positive regulation of CD8-positive, alpha-beta T cell proliferation / negative regulation of epithelial cell differentiation / CD8 receptor binding ...forebrain astrocyte development / positive regulation of memory T cell activation / T cell mediated cytotoxicity directed against tumor cell target / TAP complex binding / Golgi medial cisterna / positive regulation of CD8-positive, alpha-beta T cell activation / CD8-positive, alpha-beta T cell activation / positive regulation of CD8-positive, alpha-beta T cell proliferation / negative regulation of epithelial cell differentiation / CD8 receptor binding / type I pneumocyte differentiation / regulation of synaptic transmission, GABAergic / epithelial tube branching involved in lung morphogenesis / Rac protein signal transduction / antigen processing and presentation of exogenous peptide antigen via MHC class I / beta-2-microglobulin binding / positive regulation of Rac protein signal transduction / skeletal muscle cell differentiation / endoplasmic reticulum exit site / Signaling by RAS GAP mutants / Signaling by RAS GTPase mutants / Activation of RAS in B cells / antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent / TAP binding / RAS signaling downstream of NF1 loss-of-function variants / protection from natural killer cell mediated cytotoxicity / RUNX3 regulates p14-ARF / SOS-mediated signalling / Activated NTRK3 signals through RAS / Activated NTRK2 signals through RAS / antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent / SHC1 events in ERBB4 signaling / antigen processing and presentation of endogenous peptide antigen via MHC class Ib / Signalling to RAS / Activated NTRK2 signals through FRS2 and FRS3 / SHC-related events triggered by IGF1R / glial cell proliferation / Estrogen-stimulated signaling through PRKCZ / SHC-mediated cascade:FGFR3 / detection of bacterium / MET activates RAS signaling / T cell receptor binding / SHC-mediated cascade:FGFR2 / Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants / Signaling by PDGFRA extracellular domain mutants / PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases / SHC-mediated cascade:FGFR4 / Signaling by CSF3 (G-CSF) / Erythropoietin activates RAS / Signaling by FGFR4 in disease / SHC-mediated cascade:FGFR1 / FRS-mediated FGFR3 signaling / Signaling by FLT3 ITD and TKD mutants / protein-membrane adaptor activity / FRS-mediated FGFR2 signaling / FRS-mediated FGFR4 signaling / Signaling by FGFR3 in disease / p38MAPK events / positive regulation of glial cell proliferation / Tie2 Signaling / FRS-mediated FGFR1 signaling / homeostasis of number of cells within a tissue / Signaling by FGFR2 in disease / striated muscle cell differentiation / GRB2 events in EGFR signaling / SHC1 events in EGFR signaling / Signaling by FLT3 fusion proteins / FLT3 Signaling / EGFR Transactivation by Gastrin / Signaling by FGFR1 in disease / NCAM signaling for neurite out-growth / CD209 (DC-SIGN) signaling / GRB2 events in ERBB2 signaling / Downstream signal transduction / Ras activation upon Ca2+ influx through NMDA receptor / SHC1 events in ERBB2 signaling / Insulin receptor signalling cascade / Constitutive Signaling by Overexpressed ERBB2 / Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants / : / : / positive regulation of receptor binding / early endosome lumen / VEGFR2 mediated cell proliferation / Nef mediated downregulation of MHC class I complex cell surface expression / negative regulation of receptor binding / DAP12 interactions / small monomeric GTPase / cellular response to iron ion / lumenal side of endoplasmic reticulum membrane / Endosomal/Vacuolar pathway / Antigen Presentation: Folding, assembly and peptide loading of class I MHC / FCERI mediated MAPK activation / peptide antigen assembly with MHC class II protein complex / cellular response to iron(III) ion / antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent / RAF activation / MHC class II protein complex / negative regulation of forebrain neuron differentiation / regulation of long-term neuronal synaptic plasticity
Similarity search - Function
Small GTPase, Ras-type / Small GTPase Ras domain profile. / Ran (Ras-related nuclear proteins) /TC4 subfamily of small GTPases / MHC class I, alpha chain, C-terminal / MHC_I C-terminus / MHC class I alpha chain, alpha1 alpha2 domains / Rho (Ras homology) subfamily of Ras-like small GTPases / Ras subfamily of RAS small GTPases / Class I Histocompatibility antigen, domains alpha 1 and 2 / Small GTPase ...Small GTPase, Ras-type / Small GTPase Ras domain profile. / Ran (Ras-related nuclear proteins) /TC4 subfamily of small GTPases / MHC class I, alpha chain, C-terminal / MHC_I C-terminus / MHC class I alpha chain, alpha1 alpha2 domains / Rho (Ras homology) subfamily of Ras-like small GTPases / Ras subfamily of RAS small GTPases / Class I Histocompatibility antigen, domains alpha 1 and 2 / Small GTPase / Ras family / Beta-2-Microglobulin / : / MHC class I-like antigen recognition-like / MHC class I-like antigen recognition-like superfamily / Rab subfamily of small GTPases / MHC classes I/II-like antigen recognition protein / : / Small GTP-binding protein domain / Immunoglobulin/major histocompatibility complex, conserved site / Immunoglobulins and major histocompatibility complex proteins signature. / Immunoglobulin C-Type / Immunoglobulin C1-set / Immunoglobulin C1-set domain / Ig-like domain profile. / Immunoglobulin-like domain / Immunoglobulin-like domain superfamily / Immunoglobulin-like fold / P-loop containing nucleoside triphosphate hydrolase
Similarity search - Domain/homology
GTPase KRas / HLA class I histocompatibility antigen, A alpha chain / Beta-2-microglobulin
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 3.095 Å
AuthorsXu, Y.
Funding support China, 1items
OrganizationGrant numberCountry
Ministry of Science and Technology (MoST, China)2021YFA1302200 China
CitationJournal: To Be Published
Title: Crystal structure of HLA-A*11:01 in complex with KRAS G12R peptide (VVVGARGVGK)
Authors: Xu, Y.
History
DepositionJul 20, 2023Deposition site: PDBJ / Processing site: PDBC
Revision 1.0Jan 29, 2025Provider: repository / Type: Initial release

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: HLA class I histocompatibility antigen, A alpha chain
B: Beta-2-microglobulin
C: KRAS G12R peptide (VVVGARGVGK)
D: HLA class I histocompatibility antigen, A alpha chain
E: Beta-2-microglobulin
F: KRAS G12R peptide (VVVGARGVGK)
G: HLA class I histocompatibility antigen, A alpha chain
H: Beta-2-microglobulin
I: KRAS G12R peptide (VVVGARGVGK)
J: HLA class I histocompatibility antigen, A alpha chain
K: Beta-2-microglobulin
L: KRAS G12R peptide (VVVGARGVGK)


Theoretical massNumber of molelcules
Total (without water)188,38112
Polymers188,38112
Non-polymers00
Water00
1
A: HLA class I histocompatibility antigen, A alpha chain
B: Beta-2-microglobulin
C: KRAS G12R peptide (VVVGARGVGK)


Theoretical massNumber of molelcules
Total (without water)47,0953
Polymers47,0953
Non-polymers00
Water0
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area4270 Å2
ΔGint-21 kcal/mol
Surface area19050 Å2
MethodPISA
2
D: HLA class I histocompatibility antigen, A alpha chain
E: Beta-2-microglobulin
F: KRAS G12R peptide (VVVGARGVGK)


Theoretical massNumber of molelcules
Total (without water)47,0953
Polymers47,0953
Non-polymers00
Water0
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area4140 Å2
ΔGint-18 kcal/mol
Surface area18970 Å2
MethodPISA
3
G: HLA class I histocompatibility antigen, A alpha chain
H: Beta-2-microglobulin
I: KRAS G12R peptide (VVVGARGVGK)


Theoretical massNumber of molelcules
Total (without water)47,0953
Polymers47,0953
Non-polymers00
Water0
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area4100 Å2
ΔGint-21 kcal/mol
Surface area19070 Å2
MethodPISA
4
J: HLA class I histocompatibility antigen, A alpha chain
K: Beta-2-microglobulin
L: KRAS G12R peptide (VVVGARGVGK)


Theoretical massNumber of molelcules
Total (without water)47,0953
Polymers47,0953
Non-polymers00
Water0
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area4160 Å2
ΔGint-20 kcal/mol
Surface area19080 Å2
MethodPISA
Unit cell
Length a, b, c (Å)118.648, 121.602, 155.814
Angle α, β, γ (deg.)90.000, 90.000, 90.000
Int Tables number19
Space group name H-MP212121
Space group name HallP2ac2ab
Symmetry operation#1: x,y,z
#2: x+1/2,-y+1/2,-z
#3: -x,y+1/2,-z+1/2
#4: -x+1/2,-y,z+1/2
Noncrystallographic symmetry (NCS)NCS domain:
IDEns-ID
11
21
31
41
12
22
32
42
13
23
33

NCS domain segments:
Dom-IDComponent-IDEns-IDBeg auth comp-IDBeg label comp-IDEnd auth comp-IDEnd label comp-IDSelection detailsAuth asym-IDLabel asym-IDAuth seq-IDLabel seq-ID
101GLYGLYLYSLYS(chain 'A' and (resid 25 through 93 or resid 95 through 299))AA25 - 922 - 69
111SERSERTRPTRP(chain 'A' and (resid 25 through 93 or resid 95 through 299))AA95 - 29872 - 275
201GLYGLYLYSLYS(chain 'D' and (resid 25 through 93 or resid 95 through 299))DD25 - 922 - 69
211SERSERTRPTRP(chain 'D' and (resid 25 through 93 or resid 95 through 299))DD95 - 29872 - 275
301GLYGLYLYSLYS(chain 'G' and (resid 25 through 93 or resid 95 through 299))GG25 - 922 - 69
311SERSERTRPTRP(chain 'G' and (resid 25 through 93 or resid 95 through 299))GG95 - 29872 - 275
401GLYGLYLYSLYS(chain 'J' and (resid 25 through 93 or resid 95 through 299))JJ25 - 922 - 69
411SERSERTRPTRP(chain 'J' and (resid 25 through 93 or resid 95 through 299))JJ95 - 29872 - 275
102METMETMETMETchain 'B'BB0 - 991 - 100
212METMETMETMETchain 'E'EE0 - 991 - 100
322METMETMETMETchain 'H'HH0 - 991 - 100
432METMETMETMETchain 'K'KK0 - 991 - 100
103VALVALVALVALchain 'F'FF1 - 31 - 3
113GLYGLYLYSLYSchain 'F'FF7 - 107 - 10
203VALVALVALVALchain 'I'II1 - 31 - 3
213GLYGLYLYSLYSchain 'I'II7 - 107 - 10
303VALVALVALVALchain 'L'LL1 - 31 - 3
313GLYGLYLYSLYSchain 'L'LL7 - 107 - 10

NCS ensembles :
ID
1
2
3

-
Components

#1: Protein
HLA class I histocompatibility antigen, A alpha chain / Human leukocyte antigen A / HLA-A


Mass: 31986.250 Da / Num. of mol.: 4
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: HLA-A, HLAA / Production host: Escherichia coli (E. coli) / References: UniProt: P04439
#2: Protein
Beta-2-microglobulin


Mass: 14165.771 Da / Num. of mol.: 4
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: B2M, CDABP0092, HDCMA22P / Production host: Escherichia coli (E. coli) / References: UniProt: P61769
#3: Protein/peptide
KRAS G12R peptide (VVVGARGVGK)


Mass: 943.145 Da / Num. of mol.: 4 / Mutation: G12R
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: KRAS, KRAS2, RASK2 / Production host: Escherichia coli (E. coli) / References: UniProt: P01116
Has protein modificationY

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 2.98 Å3/Da / Density % sol: 58.77 %
Crystal growTemperature: 293.15 K / Method: vapor diffusion / Details: Ammonium sulfate, Sodium cacodylate, PEG 4000

-
Data collection

DiffractionMean temperature: 80 K / Serial crystal experiment: N
Diffraction sourceSource: SYNCHROTRON / Site: NFPSS / Beamline: BL19U1 / Wavelength: 0.97852 Å
DetectorType: DECTRIS PILATUS3 6M / Detector: PIXEL / Date: Nov 18, 2022
RadiationProtocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 0.97852 Å / Relative weight: 1
ReflectionResolution: 3.095→50 Å / Num. obs: 41628 / % possible obs: 99.1 % / Redundancy: 13 % / Biso Wilson estimate: 52.9 Å2 / CC1/2: 0.981 / Net I/σ(I): 5.51
Reflection shellResolution: 3.095→3.205 Å / Num. unique obs: 52883 / CC1/2: 0.716

-
Processing

Software
NameVersionClassification
PHENIX1.17.1_3660refinement
PHENIX1.17.1_3660phasing
Cootmodel building
XDSdata scaling
RefinementMethod to determine structure: MOLECULAR REPLACEMENT / Resolution: 3.095→25.39 Å / SU ML: 0.5311 / Cross valid method: FREE R-VALUE / σ(F): 1.34 / Phase error: 40.1212
Stereochemistry target values: GeoStd + Monomer Library + CDL v1.2
RfactorNum. reflection% reflection
Rfree0.3474 3762 4.78 %
Rwork0.2957 74937 -
obs0.2981 41628 99.21 %
Solvent computationShrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL
Displacement parametersBiso mean: 54.74 Å2
Refinement stepCycle: LAST / Resolution: 3.095→25.39 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms12540 0 0 0 12540
Refine LS restraints
Refine-IDTypeDev idealNumber
X-RAY DIFFRACTIONf_bond_d0.002412897
X-RAY DIFFRACTIONf_angle_d0.570717488
X-RAY DIFFRACTIONf_chiral_restr0.04151774
X-RAY DIFFRACTIONf_plane_restr0.00392316
X-RAY DIFFRACTIONf_dihedral_angle_d23.69481736
LS refinement shell
Resolution (Å)Rfactor RfreeNum. reflection RfreeRfactor RworkNum. reflection RworkRefine-ID% reflection obs (%)
3.095-3.130.44421230.41162540X-RAY DIFFRACTION90.61
3.13-3.170.37651530.38672779X-RAY DIFFRACTION99.52
3.17-3.220.42361250.37342786X-RAY DIFFRACTION99.22
3.22-3.260.41511390.37172797X-RAY DIFFRACTION99.76
3.26-3.310.441300.37252810X-RAY DIFFRACTION99.73
3.31-3.360.41271460.37092775X-RAY DIFFRACTION99.83
3.36-3.420.43621370.35582801X-RAY DIFFRACTION99.8
3.42-3.480.3691310.33572828X-RAY DIFFRACTION99.76
3.48-3.540.36421560.31372737X-RAY DIFFRACTION99.59
3.54-3.610.33081520.33422790X-RAY DIFFRACTION99.49
3.61-3.680.38451240.32162787X-RAY DIFFRACTION99.62
3.68-3.760.42081380.30182785X-RAY DIFFRACTION99.73
3.76-3.850.41511320.29472818X-RAY DIFFRACTION99.53
3.85-3.950.38351500.29572762X-RAY DIFFRACTION99.39
3.95-4.050.30771390.29222777X-RAY DIFFRACTION99.56
4.05-4.170.35071480.28462761X-RAY DIFFRACTION99.45
4.17-4.30.31021480.26272750X-RAY DIFFRACTION99.35
4.3-4.460.30231220.25272835X-RAY DIFFRACTION99.7
4.46-4.640.25961450.25042767X-RAY DIFFRACTION99.73
4.64-4.840.27431400.24652783X-RAY DIFFRACTION99.39
4.84-5.10.3061500.26792772X-RAY DIFFRACTION99.66
5.1-5.410.29881400.26192784X-RAY DIFFRACTION99.63
5.42-5.830.3421420.28652791X-RAY DIFFRACTION99.52
5.83-6.410.36551490.29792782X-RAY DIFFRACTION99.63
6.41-7.310.39171360.28632780X-RAY DIFFRACTION99.62
7.31-9.140.3241380.24752788X-RAY DIFFRACTION99.39
9.14-25.390.3021290.26012772X-RAY DIFFRACTION98.71

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more